Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Sarcoma 2Neoplasm Metastasis 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Motor Activity 1Lung Neoplasms 1HER2-positive Breast Cancer 1HER2 Positive Breast Cancer 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Diseases 1Breast Cancer Female 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Radiotherapy 6Magnetic Resonance Spectroscopy 5Radiation 4Neoadjuvant Therapy 4Methods 3Mastectomy, Segmental 3High-Energy Shock Waves 3Early Intervention, Educational 3Counseling 3Biopsy 3Tamoxifen 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Practice Guidelines as Topic 2Lapatinib 2Immunohistochemistry 2Genetic Testing 2Diet 2Cryosurgery 2Chemotherapy, Adjuvant 2Caregivers 2Brachytherapy 2perflutren 1black cohosh root extract 1Zolpidem 1Yoga 1Venlafaxine Hydrochloride 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Intraductal, Noninfiltrating × Trastuzumab × Clear all
NCT00496808 2020-09-23

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

M.D. Anderson Cancer Center

Phase NA Completed
69 enrolled 6 charts
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡